Acquired immune deficiency syndrome: The glucocorticoid solution

Medical Hypotheses

Volumn 47, Issue 1, 1996, Pages 49-54

  Corley, P A ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HYPOTHESIS; PRIORITY JOURNAL; REVIEW;

EID: 0030016560     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(96)90043-2     Document Type: Article

References (48)

1. Corley P A. HIV and the cortisol connection: a feasible concept of the process of AIDS. Med Hypotheses 1995; 44: 483-489.
2. Smith J S, Kawa S, Cloyd M W, Thompson E B. Interactions between human immunodeficiency virus infection and hormonal pathways: enhancement of calcium-induced but reduction of glucocorticoid-induced cell death. Endocrinology 1993; 133: 1085-1091.
3. Galli M, Bevilacqua M, Norbiato G et al. Evaluation of ACTH, cortisol and glucocorticoid receptors (GR) in 23 AIDS patients. Int Conf AIDS 1991; 7: 45 (abstract no. W.B.86).
4. Haq A, al-Hussein K, Lee J, al-Sedairy S. Changes in peripheral blood lymphocyte subsets associated with marathon running. Med Sci Sports Exerc 1993; 25: 186-190.
5. Gabriel H, Schwarz L, Steffens G, Kindermann W. Immunoregulatory hormones, circulating leucocyte and lymphocyte subpopulations before and after endurance exercise of different intensities. Int J Sports Med 1992; 13: 359-366.
6. + T lymphocytes in multiple sclerosis. J Clin Immunol 1993; 13: 113-118.
7. Hennig J, Laschefski U, Becker H, Rammsayer T, Netter P. Immune cell and cortisol responses to physically and pharmacologically induced lowering of body core temperature. Neuropsychobiology 1993; 28: 82-86.
8. - thymocytes represents an intermediate stage in intrathymic repertoire selection. Int Immunol 1992; 4: 153-161.
9. Charles G, Machowski R, Brohee D, Wilmotte J, Kennes B. Lymphocyte subsets in major depressive patients. Influence of anxiety and corticoadrenal overdrive. Neuropsychobiology 1992; 25: 94-98.
10. Biglino A, Forno B, Pollono A M, Limone P. Altered ACTH and cortisol response to corticotropin releasing hormone (CRH) in HIV-1 infection. Possible role of interleukin-1 in direct adrenal stimulation. Int Conf AIDS 1993; 9: 185 (abstract no. POA140306).
11. Kasckow J W, Mulcahey J J, Han J H et al. Interleukin-1 alpha induces corticotropin-releasing factor secretion and synthesis from NPLC-KC cells through various second messenger pathways. Synapse 1994; 18: 354-358.
12. Sandi C, Guaza C. Evidence for a role of nitric oxide in the corticotropin-releasing factor release induced by interleukin-1 beta. Eur J Pharmacol 1995; 274: 17-23.
13. Hashemi F B, Hughes T K, Smith E M. Characterization of immunoreactive corticotropin in lymphocytes infected with human immunodeficiency virus. Abstr Gen Meet Am Soc Microbiol 1992; 92: 412 (abstract no. T-26).
14. Sundar S K, Cierpial M A, Kamaraju L S et al. Human immunodeficiency virus glycoprotein (gp120) infused into rat brain induces interleukin 1 to elevate pituitary-adrenal activity and decrease peripheral cellular immune responses. Proc Natl Acad Sci USA 1991; 88: 11246-11250.
15. Clouse K A, Farrar W L, Cosentino L M et al. The amino terminus of the HIV gp120 envelope protein may be necessary for stimulation of monokine secretion. Int Conf AIDS 1991; 7: 164 (abstract no. W.A.1288).
16. Tyring S K, Cauda R, Tumbarello M et al. Synthetic peptides corresponding to sequences in HIV envelope gp41 and gp120 enhance in vitro production of interleukin-1 and tumor necrosis factor but depress production of interferon-alpha, interferon-gamma and interleukin-2. Viral Immunol 1991; 4: 33-42.
17. Uehara Y, Shimizu H, Sato N, Mura Y S, Mori M. The dipeptide Lys-Pro attenuates interleukin-1 beta-induced anorexia. Peptides 1993; 14: 175-178.
18. Davidson J, Milton A S, Rotondo D. Alpha-melanocyte-stimulating hormone suppresses fever and increases in plasma levels of prostaglandin E2 in the rabbit. J Physiol (Lond) 1992; 451: 491-502.
19. Swope V B, Sauder D N, McKenzie R C et al. Synthesis of interleukin-1 alpha and beta by normal human melanocytes. J Invest Dermatol 1994; 102: 749-753.
20. Dominy S S. Is peptide T, an octapeptide sequence found in the external glycoprotein coat of the human immunodeficiency virus (HIV), a fragment of a retro-copy of the gamma-3-MSH neuropeptide? Med Hypotheses 1988; 27: 1-4.
21. Ramsdale T E, Andrews P R, Nice E C. Verification of the interaction between peptide T and CD4 using surface plasmon resonance. FEBS Lett 1993; 333: 217-222.
22. Corley P A. AIDS and SLE: a reverse process of the same disease. Med Hypotheses 1992; 37: 85-91.
23. Race E, Stein C A, Chargelegue D, Oxford J S, Aston R. Peptide T antagonises the potentiation of HIV-1 replication by TNF alpha. Int Conf AIDS 1994; 10: 113 (abstract no. PA0333).
24. Buzy J, Brenneman D E, Pert C B et al. Potent gp120-like neurotoxic activity in the cerebrospinal fluid of HIV-infected individuals is blocked by peptide T. Brain Res 1992; 598: 10-18.
25. Bridge T P, Heseltine P N, Parker E S et al. Results of extended peptide T administration in AIDS and ARC patients. Psychopharmacol Bull 1991; 27: 237-245.
26. Doob P R, MacFadden D K. The impact of peptide T on HIV-related fatigue and health-related quality of life. Int Conf AIDS 1992; 8: 73 (abstract no. PuB 7149).
27. MacFadden D K, Doob P R. Peptide T: onset of action and palliation of symptoms with peptide T in HIV disease. Int Conf AIDS 1992; 8: 103 (abstract no. PuB 7328).
28. MacFadden D K, Doob P R. Role of peptide T in palliation of HIV-1-related painful peripheral neuropathy. Int Conf AIDS 1991; 7: 225 (abstract no. W.B.2173).
29. Macfadden D K, Phipps D J, Doob P R. Peptide T immunomodulation: patient data. Int Conf AIDS 1993; 9: 496 (abstract no. PO-B28-2164).
30. Smith E M, Hughes T K Jr, Hashemi F, Stefano G B. Immunosuppressive effects of corticotropin and melanotropin and their possible significance in human immunodeficiency virus infection. Proc Natl Acad Sci USA 1992; 89: 782-786.
31. Zhou A, Bloomquist B T, Mains R E. The prohormone convertases PC1 and PC2 mediate distinct endoproteolytic cleavages in a strict temporal order during proopiomelanocortin biosynthetic processing. J Biol Chem 1993; 268: 1763-1769.
32. Soudeyns H, Geleziunas R, Shymala G, Hiscott J, Wainberg M A. Identification of a novel glucocorticoid response element within the genome of the human immunodeficiency virus type 1. Virology 1993; 194: 758-768.
33. Kolesnitchenko V, Snart R S. Regulatory elements in the human immunodeficiency virus type 1 long terminal repeat LTR (HIV-1) responsive to steroid hormone stimulation. AIDS Res Hum Retroviruses 1992; 8: 1977-1980.
34. Justement J S, Poli G, Fauci A S. Glucocorticoids act synergistically with recombinant cytokines to induce HIV expression in chronically infected promonocyte cells. Int Conf AIDS 1990; 6: 162 (abstract no. S.A.322).
35. Danel-Moore L, Kawa S, Kalmaz G D, Bessman D, Thompson E B. Induction of CD8 antigen and suppressor activity by glucocorticoids in a CEM human leukemic cell clone. Leuk Res 1993; 17: 501-506.
36. + cytotoxic T lymph-ocytes transduced with an IL-1 receptor retrovirus. J Immunol 1994; 153: 1527-1535.
37. Sinicco A, Biglino A, Gioannini P. Study of 31 acute HIV-1 infection (API). Int Conf AIDS 1994; 10: 208 (abstract no. PB0262).
38. Sandyk R, Awerbuch G I. Nocturnal plasma melatonin and alpha-melanocyte stimulating hormone levels during exacerbation of multiple sclerosis. Int J Neurosci 1992; 67: 173-186.
39. Morrey K M, McLachlan J A, Serkin C D, Bakouche O. Activation of human monocytes by the pineal hormone melatonin. J Immunol 1994; 153: 2671-2680.
40. Pioli C, Caroleo M C, Nistico G, Doria G. Melatonin increases antigen presentation and amplifies specific and non specific signals for T-cell proliferation. Int J Immunopharmacol 1993; 15: 463-468.
41. Maestroni G J. The immunoneuroendocrine role of melatonin. J Pineal Res 1993; 14: 1-10.
42. Brooks E H. Eumelanin pigmentation is a host-specific factor influencing immune response and HFV progression. Int Conf AIDS 1992; 8: 15 (abstract no. PuA 6026).
43. Kawa S, Cloyd M W, Thompson E B. Resistance to HIV-1 infection by CD4-positive lymphoid cells that vary in their glucocorticoid receptors and responses [letter]. In Vitro Cell Dev Biol Anim 1993; 29A: 255-257.
44. Norbiato G, Galli M, Righini V, Moroni M. The syndrome of acquired glucocorticoid resistance in HIV infection. Baillières Clin Endocrinol Metab 1994; 8: 777-787.
45. Karwowska S, Zolla-Pazner S. Passive immunization for the treatment and prevention of HIV infection. Biotechnol Ther 1991; 2: 31-48.
46. Lacour J P, Ghanem G, Dellamonica P, Cassuto J P, Ortonne J P. [Relationship between skin hyperpigmentation in AIDS and serum alpha-melanocyte stimulating hormone level (letter)]. Presse Med 1992; 21: 2062.
47. Cloyd M W. A polymorphic human gene(s) for resistance to infection by certain strains of HIV-1. Int Conf AIDS 1993; 9: 242 (abstract no. PO-A26-0644).
48. Cloyd M W, Moore B E. Spectrum of biological properties of human immunodeficiency virus (HIV-1) isolates. Virology 1990; 174: 103-116.